Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Collegium Pharmaceutical Inc COLL

Healthcare
Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed... see more

Bullboard (NDAQ:COLL)

View:
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Sep 18, 2024 2:33pm

When the Price of (COLL) Talks, People Listen

Just In: $COLL When the Price of (COLL) Talks, People Listen2024-09-18 11:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to ...more  
16
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Jun 07, 2024 2:00pm

Buy Recommendation Issued On COLL By Jefferies

JUST IN: $COLL Buy Recommendation Issued On COLL By Jefferies2024-06-07 06:30:03 ET Jefferies analyst issues BUY recommendation for COLL on June 7, 2024 04:58AM ET. The previous analyst recommendation ...more  
29
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities